Literature DB >> 11323441

A 49-residue peptide from adhesin F1 of Streptococcus pyogenes inhibits fibronectin matrix assembly.

B R Tomasini-Johansson1, N R Kaufman, M G Ensenberger, V Ozeri, E Hanski, D F Mosher.   

Abstract

F1 is an adhesin of Streptococcus pyogenes which binds the N-terminal 70-kDa region of fibronectin with high affinity. The fibronectin binding region of F1 is comprised of a 43-residue upstream domain and a repeat domain comprised of five tandem 37-residue sequences. We investigated the effects of these domains on the assembly of fibronectin matrix by human dermal fibroblasts, MG63 osteosarcoma cells, or fibroblasts derived from fibronectin-null stem cells. Subequimolar or equimolar concentrations of recombinant proteins containing both the upstream and repeat domains or just the repeat domain enhanced binding of fibronectin or its N-terminal 70-kDa fragment to cell layers; higher concentrations of these recombinant proteins inhibited binding. The enhanced binding did not result in greater matrix assembly and was caused by increased ligand binding to substratum. In contrast, recombinant or synthetic protein containing the 43 residues of the upstream domain and the first 6 residues from the repeat domain exhibited monophasic inhibition with an IC(50) of approximately 10 nm. Truncation of the 49-residue sequence at its N or C terminus caused loss of inhibitory activity. The 49-residue upstream sequence blocked incorporation of both endogenous cellular fibronectin and exogenous plasma fibronectin into extracellular matrix and inhibited binding of 70-kDa fragment to fibronectin-null cells in a fibronectin-free system. Inhibition of matrix assembly by the 49-mer had no effect on cell adhesion to substratum, cell growth, formation of focal contacts, or formation of stress fibers. These results indicate that the 49-residue upstream sequence of F1 binds in an inhibitory mode to N-terminal parts of exogenous and endogenous fibronectin which are critical for fibronectin fibrillogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323441     DOI: 10.1074/jbc.M103467200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Functional characterization of the interaction between bacterial adhesin multivalent adhesion molecule 7 (MAM7) protein and its host cell ligands.

Authors:  Anne Marie Krachler; Kim Orth
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Ligation of the fibrin-binding domain by β-strand addition is sufficient for expansion of soluble fibronectin.

Authors:  Lisa M Maurer; Wenjiang Ma; Nathan L Eickstaedt; Ian A Johnson; Bianca R Tomasini-Johansson; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

3.  Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

4.  The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin.

Authors:  Bianca R Tomasini-Johansson; Douglas S Annis; Deane F Mosher
Journal:  Matrix Biol       Date:  2006-03-06       Impact factor: 11.583

5.  Fibrillin assembly requires fibronectin.

Authors:  Laetitia Sabatier; Daliang Chen; Christine Fagotto-Kaufmann; Dirk Hubmacher; Marc D McKee; Douglas S Annis; Deane F Mosher; Dieter P Reinhardt
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

6.  Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.

Authors:  Iñigo Valiente-Alandi; Sarah J Potter; Ane M Salvador; Allison E Schafer; Tobias Schips; Francisco Carrillo-Salinas; Aaron M Gibson; Michelle L Nieman; Charles Perkins; Michelle A Sargent; Jiuzhou Huo; John N Lorenz; Tony DeFalco; Jeffery D Molkentin; Pilar Alcaide; Burns C Blaxall
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

7.  Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms.

Authors:  Jeniel E Nett; Jonathan Cabezas-Olcoz; Karen Marchillo; Deane F Mosher; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cells.

Authors:  Mark S Filla; Kaylee D Dimeo; Tiegang Tong; Donna M Peters
Journal:  Exp Eye Res       Date:  2017-08-30       Impact factor: 3.467

9.  Fibronectin fibrillogenesis regulates three-dimensional neovessel formation.

Authors:  Xiaoming Zhou; R Grant Rowe; Nobuaki Hiraoka; Jerry P George; Denis Wirtz; Deane F Mosher; Ismo Virtanen; Michael A Chernousov; Stephen J Weiss
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

10.  Display of cell surface sites for fibronectin assembly is modulated by cell adherence to (1)F3 and C-terminal modules of fibronectin.

Authors:  Jielin Xu; Eunnyung Bae; Qinghong Zhang; Douglas S Annis; Harold P Erickson; Deane F Mosher
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.